Equals 5 Secures Strategic Investment from Baleon Capital to Power the Industry's Most Precise HCP Marketing Platform
Summary
This investment marks a significant milestone in Equals 5s mission to provide unparalleled, precisely targeted, and attributable HCP marketing solutions for the pharmaceutical industry.With this partnership, Equals 5 will further enhance its innovative platform, which empowers pharmaceutical companies and agencies to seamlessly build audiences, execute campaigns, and precisely engage HCPs across 20+ channels in one place. "Our platform is transforming pharmaceutical marketing by delivering precisely targeted HCP campaigns across social media channels and beyond, with clear, attributable performance insights at the NPI level," said Roman Makukh, Co-Founder and CEO at Equals 5. "With Baleon Capitals investment, we will accelerate platform advancements, introduce AI-powered solutions, expand HCP reach across more channels with superior PLD, and much more - all aimed at scaling to meet the surging demand from our clients. The Equals 5 All-in-One Healthcare Marketing Platform enables to easily set up and launch HCP marketing campaigns on 20+ channels in one place while using a unique 100% NPI-level targeting technology to precisely reach the HCPs on your target lists and gather NPI-level reporting data on all engagements.About Baleon Capital specializes in investing in early-growth stage healthcare and B2B technology companies, providing both capital and operational support to accelerate success. Focusing on businesses with strong revenue growth and innovative market positioning, Baleon Capital partners with founders to scale their companies from initial investment through exit.